Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways [NA]
This clinical trial update reports completion of a study led by Majed Aljeraisy examining a collaborative approach to monitoring patient-cen…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: The Angel® Catheter Pivotal Clinical Trial [NA]
The Angel Catheter pivotal clinical trial has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Safety of a Diagnostic Strategy With D-Dimer Testing for PE [Phase 3]
A Phase 3 trial assessing the safety of a D-Dimer based diagnostic strategy for suspected pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement [Phase 2]
A Phase 2 trial comparing TeaRx's Xa factor direct inhibitor to enoxaparin for prevention of venous thromboembolism after total knee replace…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer [Phase 3]
Phase 3 trial completed evaluating nadroparin in patients with lung, pancreatic, or prostate cancer, focusing on venous thrombosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of low-molecular weight heparin for thromboprophylaxis in acutely ill medical patients ha…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Xarelto Regulatory Post-Marketing Surveillance
This update reports results from Bayer’s post-marketing surveillance study of rivaroxaban (Xarelto) in patients with venous thromboembolism,…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Dose-confirmatory Bridging Study in Total Hip Replacement [Phase 3]
Phase 3 dose-confirmatory bridging trial in total hip replacement sponsored by Bayer has completed, focusing on prevention of venous thrombo…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
A completed non-interventional Bayer-sponsored study assessing compliance with venous thromboembolism prophylaxis in hip or knee replacement…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty
A clinical trial evaluating rivaroxaban (Xarelto) for preventing venous thromboembolism after hip or knee arthroplasty has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Dose-confirmatory Bridging Study in Total Knee Replacement [Phase 3]
A Phase 3 dose-confirmatory bridging trial in total knee replacement assessing venous thromboembolism has the study status listed as complet…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism
This completed cohort study investigates identifying cancer patients at high risk of venous thromboembolism, with emphasis on deep vein thro…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) [Phase 3]
Phase 3 trial update evaluating prolonged anticoagulation after a first episode of idiopathic proximal deep vein thrombosis. The study statu…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Pharmacogenetic Dosage Algorithm for Acenocoumarol
A completed clinical trial evaluating a pharmacogenetic dosing algorithm for acenocoumarol intended to tailor anticoagulation dosing. Condit…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer [Phase 4]
A Phase 4 trial evaluating rivaroxaban to prevent venous thromboembolism in Asian patients with cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age [Phase 2]
Phase 2 study evaluating the safety and tolerability of dabigatran etexilate oral solution in children aged 1 to under 12 with venous thromb…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months [NA]
A completed clinical trial evaluated whether D-dimer testing can identify patients with a first unprovoked venous thromboembolism who can sa…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients [Phase 4]
Phase 4 trial completed and results posted evaluating dalteparin for primary venous thromboembolism prophylaxis in pancreatic cancer patient…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: High-dose Periop Statins for Prevention of DVT [NA]
A completed clinical trial investigated high-dose perioperative statins to prevent deep vein thrombosis in patients undergoing gynecologic o…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants [Phase 1]
Phase 1 study completed to assess how clarithromycin affects the pharmacokinetics of apixaban in healthy participants, evaluating a potentia…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
A completed clinical trial update evaluating a predictive approach for bleeding risk on anticoagulant therapy in patients with venous thromb…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care [NA]
This clinical trial update compares patient outcomes under different delivery models for anticoagulation care in venous thromboembolism mana…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery [Phase 3]
A Phase 3 prospective trial comparing preoperative versus postoperative venous thromboembolism prophylaxis in patients undergoing major colo…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Obstructive Sleep Apnea and Venous Thromboembolism
Clinical trial studying obstructive sleep apnea and venous thromboembolism was terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age [Phase 2]
Phase 2 pediatric trial evaluating tolerability, PK/PD and safety of dabigatran etexilate oral liquid in infants under 1 year; study complet…